Human polymorphonuclear leukocytes (PMN) activated by fMLP (in the presence of CaCI,, fibrinogen, and cytochalasin B) were able t o induce aggregation, cytoplasmic Ca'+ increase, and thromboxane & production in coincubated autologousplatelets.Cell-freesupernatantspreparedfromn-formyl--methionyl-leucyl-phenylalanine (fMLP)-stimulated PMN were able also t o induce platelet activation. Antibodies against cathepsin G and different serin protease inhibitors completely suppressed the activity of PMN-derived supernatants, indicating that cathepsin G is the major platelet activator released by PMN in our system. However, antiproteinases only partially affected platelet activation induced by PMN in mixed cell suspensions. Superoxide dismutase and catalase added t o the cell suspension did not affect platelet activation nor potentiated serin protease inhibitors, making a role for short-lived oxygen radicals in our experimental system unlikely. Electron microscopic observation of stirred NUMBER OF epidemiologic studies have shown a A positive correlation between white blood cell counts and risk of ischemic disease.' Experimental studies in animals also suggest that polymorphonuclear leukocytes (PMN) play an important role in the pathophysiology of myocardial infarction. Accumulation of PMN at the site of myocardial ischemia may exacerbate tissue injury through the release of oxygen radicals and proteolytic enzymes. ' Furthermore, an increased functional activity of PMN in vitro from patients with stable angina has been demonstrated. In vivo activation of PMN in patients with unstable angina and myocardial infarction is manifested by increased plasma levels of a peptide from the fibrinogen BP chain, a specific product of fibrin(ogen) degradation by neutrophil elastase. PMN activation in unstable angina suggests that patients who will develop acute myocardial ischemia may have abnormal leukocyte function before the onset of an acute event? Recently, several studies have tried to shed more light on the mechanisms by which PMN could contribute to vascular occlusion.
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Platelet activation induced by stimulated PMN has, in fact, been demonstrated in animals and in Leukocyte-derived products may promote platelet aggregation, serotonin release, and platelet cytoplasmic calcium increa~e.~."
In a previous study PMN challenged with different agonists induced platelet activation, measured as platelet aggregation, cytoplasmic calcium increase, and thromboxane B, (TxB,) produ~tion.'~ BN-52021, a platelet activating factor (PAF) receptor antagonist, did not affect platelet activation in mixed cellular suspensions by PMN challenged with n-formyl-methionyl-leucyl-phenylalanine (fMLP), suggesting that PAF is not involved in this phenomenon. Aspirin, at concentrations completely blocking TxB, production, did not influence aggregation or platelet cytoplasmic Ca2+ increase (in mixed cell suspensions), suggesting that TxA, synthesis was not essential for PMN-induced platelet activation. Activated PMN released platelet activating material in extracellular medium as indicated by PMN-derived mixed cell suspensions preincubated for 2 minutes at 37°C before stimulation showed a close PMN-platelets contact without any morphologic or biochemical event suggesting platelet activation. Preincubation of the cells without stirring t o minimize PMN-platelet interaction before stimulation did not modify subsequent aggregation and platelet cytoplasmic Ca'+ increase in control samples. However, in this condition trypsin inhibitor from soybean completely prevented PMNinduced platelet activation. In samples preincubated without stirring in the presence of the antiproteinase, activated PMN sticked together but platelets preserved their discoid shape and did not appear significantly activated. We propose that membrane-to-membrane contact could create a microenvironment in which cathepsin G, discharged from stimulated PMN on adherent platelets, is protected from antiproteinases. 0 1991 by The American Society of Hematology.
supernatant activity. As the latter activity was dependent on pretreatment of the PMN with cytochalasin B, a substance that enhances secretion of granule-bound material to the cell exterior, it was suggested that some lysosomal enzyme would be the mediator of platelet stimulation. This activity, moreover, was completely inhibited by soybean trypsin inhibitor. Cathepsin G and elastase, two neutral serine proteases contained in the azurophilic granules of PMN, had previously been shown to stimulate platelet funcIn vitro studies of elastase-mediated proteolysis by PMN showed that enzymes released from activated PMN can degrade susceptible substrates in the presence of antiproteinases, thereby raising the possibility that PMN-associated proteinases are more resistant than are the free tion. 12,13, 15 
EVANGELISTA ET AL
We examined whether this possibility also applied to protease-mediated platelet activation by fMLPstimulated PMN. If so, this phenomenon could also occur in circulating blood, which is replete with a spectrum of proteinase inhibitors.'l Therefore, we tested the effect of different antiproteinase on platelet activation induced by PMN-derived supernatant or by PMN in mixed cell suspensions.
MATERIALS AND METHODS

Chemicals.
Superoxide dismutase, catalase, cytochrome C, fMLP, phenolphthalein, phenolphthalein glucuronic acid, prostaglandin E, (PGE,), cytochalasin B, N-2-hydroxyethyl piperazine-N'-Zethanesulfonic acid (HEPES), ethylene glycol-bis (b-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), al-antitrypsin, and soybean trypsin inhibitor (1 mg protein inhibiting 3 to 5 mg trypsin and chymotrypsin with activities of approximately 10,000 BAEE and 40 BTEE unitdmg protein, respectively) were purchased from Sigma Chemical Co (St Louis, MO); the specific proteinase inhibitor for cathepsin G and elastase, eglin C (recombinant CGP 32968) was kindly provided by Ciba Geigy (Basel, Switzerland); antihuman cathepsin G and antihuman elastase antibodies were from ICN Immunobiologicals (Lisle, IL); cathepsin G purified from human PMN was from Calbiochem (San Diego, CA); egg-white lysozyme and Micrococcus luteus were purchased from Boehringer Mannheim (Mannheim, Germany); Dextran T 500 and Ficoll Hypaque from Pharmacia Fine Chemicals (Uppsala, Sweden); Triton X-100 was obtained from Aldrich Chimica S.r.1. (Milano, Italy); purified human fibrinogen from Kabi Diagnostica (Stockholm, Sweden); aequorin from Dr J. Blinks (Mayo Clinic, Rochester, MN). Anti-cathepsin G and anti-elastase antibodies obtained as sheep Ig fraction in phosphate-buffered saline (PBS) containing 0.1% NaN, and 0.01% thiomersal were dialyzed overnight at 4°C against PBS pH 7.4, stored in aliquots at -20"C, and thawed just before use.
PMN were isolated from citrated human blood as described.22 PMN were washed and resuspended in HEPES-Tyrode buffer (pH 7.4) containing: 129 mmol/L NaC1, 9.9 mmol/L NaHCO,, 2.8 mmol/L KCI, 0.8 mmol/L KH,PO,, 0.8 mmol/L MgC1,-6H2O, 5.6 mmol/L Dextrose, 10 mmol/L HEPES, and 1 mmol/L CaC1,. Cellular suspensions (0.5 x lo7 cells/mL) contained 95% PMN; an average of 1 plateletno leukocytes was usually observed. Autologous platelets were washed and loaded with aequorin according to Yamaguchi et al?' Previous experiments showed that this procedure did not modify platelet function in our experimental condition.
Aequorin-loaded platelets ( 108 cells/ mL), PMN (0.5 x IO7 cells/mL), or a mixture of the two cells (plateletsiPMN ratio = 20) were incubated in a final volume of 1 mL in the presence of 1 mmol/L CaZ+, 0.38 mg/mL fibrinogen, and 2.5 pg/mL cytochalasin B in the "Platelet Ionized Calcium Aggregometer" (PICA Chrono-Log, Mascia Brunelli, Milano, Italy) for 2 minutes at 37°C under constant stirring at 1,000 rpm, unless otherwise specified, with or without al-antitrypsin, soybean trypsin inhibitor, eglin C, superoxide dismutase, and catalase. fMLP or purified cathepsin G were then added to the cell suspension and aggregation and luminescence were recorded simultaneously on a Dual Channel Strip Chart Recorder (ChronoLog). Three minutes after stimulus the samples were cooled to 0°C and centrifuged in an Eppendorf centrifuge for 1.5 minutes. Supernatants were collected and stored at -20°C for TxB, assay and lysosomal enzyme activity. Cathepsin G activity in PMN and mixed cell suspension was determined by continuous monitoring of Preparation of PMN and aequorin-loaded platelets.
Experimental procedures.
the specific chromogenic substrate N-succinyl-Ala-Ala-Pro-Phe-pnitroanilide hydrolysis according to Nakajima et al." Briefly, 5 FL of a 100 mmol/L solution of the specific synthetic substrate in N-methypirrolidinone (final concentration 0.5 mmol/L) was added to the cell suspension before the addition of the stimulus and its cleavage was monitored by following the release of p-nitroanilide at 410 nm, in the supernatant prepared 1 minute after cell stimulation. The activity measured in the samples was then compared with a standard curve obtained by measuring the activity of different concentrations of purified cathepsin G. Lysozyme activity was determined by measuring the lysis of the substrate M luteus, at 540 nm and comparing the results with those obtained with known amounts of egg-white lysozyme.15 @-glucuronidase activity was determined using phenolphthalein glucuronate as substrate, monitoring its cleavage at 540 nm. 25 Superoxide anion production was determined by measuring the reduction of cytochrome C as described,26 and expressed as nanomoles of cytochrome C reduced by lo6 PMNI40 min.
Preliminary experiments showed that in our experimental conditions fMLP to mol/L) was able to trigger secretion of both lysozyme and @-glucuronidase and to induce superoxide anions production from PMN (Table 1) . No lysozyme and very limited (less than 5 p,g substrate cleavediml) @-glucuronidase activity were detectable in platelets. PMN enzymatic release was not modified by the presence of platelets. @-glucuronidase and lysozyme activity were similar in supernatants from PMN and a mixed cell suspension challenged with 1 pmol/L of fMLP. p-glucuronidase activity was 38. 6 3.1 and 38. Figures are means k SE (n = 10). At the highest fMLP concentration used mol/L) @-glucuronidase and lysozyme release were 44.3% 2 2.9% and 58.3% k 3.2% of total enzyme content, respectively. The total enzyme activities were obtained by solubilizing the cells in Triton X-100.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From To study the effect of PMN-released products on platelet activation, 800 I.LL of supernatants (20-second spin in an Eppendorf centrifuge [Leitz, Milano, Italy]) from PMN (0.5 x l0'/800 KL) stimulated for 1 minute with fMLP mol/L) were mixed with platelets in the aggregometer and aggregation and luminescence signals were recorded. Antibodies anti-cathepsin G, anti-elastase, a1-antitrypsin, soybean trypsin inhibitor, or eglin C were added to supernatant immediately before addition to platelets. Supernatants from unstimulated PMN were unable to induce any measurable platelet activation.
We evaluated the possibility that a close membrane-to-membrane contact between PMN and platelet occurring in mixed cell suspension preincubated at 37°C at 1,000 rpm stirring could result in the protection of cathepsin G-induced platelet activation. For this purpose, experiments were performed in which the inhibitoy effect of soybean trypsin inhibitory was tested in samples preincubated with or without stirring. In the latter condition the stirrer was switched on immediately before addition of the stimulus. p-glucuronidase and lysozyme release was similar in both conditions of stirring in the presence and in the absence of soybean trypsin inhibitor (not shown).
Portions of all control and experimental samples were prepared for study in the electron microscope, as previously reported?' Briefly, the samples were mixed with an equal volume of 0.1% glutaraldehyde in White's saline for 15 minutes and sedimented to pellets in a tabletop centrifuge. Supernatant was discarded and the pellet mixed with 3% glutaraldehyde in the same buffer (White's saline). After 1 hour in 3% glutaraldehyde the samples were combined with fresh 3% glutaraldehyde and shipped overnight to another laboratory for further processing. The samples after arrival were fixed in 1% osmic acid in distilled water containing 0.1% potassium ferrocyanide. The sam-
Experiments with PMN supematants.
Experiments with different stimng conditions. Morphologic studies. ples were then dehydrated in a series of alcohols, embedded in Epan 812, and sectioned on an LKB ultramicrotome. All observations were made in a Philips electron microscope on sections contrasted with uranyl acetate and lead citrate.
RESULTS
As already ~h o w n , '~ platelet aggregation, cytoplasmic Ca2+ increase, and TxB, production were induced by PMN in mixed cellular suspensions challenged with 1 pmol/L fMLP, or by supernatants obtained from PMN 1 minute after stimulation with 1 pmol/L fMLP. This stimulus was unable to induce aggregation, cytoplasmic CaZ' increase, and TxB, production in samples containing platelets alone. On the contrary, fMLP induced a limited, but concentrationdependent aggregation of PMN, reaching the maximum (3.0 ? 0.2 cm) at 1 pmol/L of the stimulus. TxB, was undetectable in NLP-stimulated PMN.
Electron microscopy ofplatelet-PMN aggregates. Electron microscopic observation of aggregates from mixed cell suspension showed both cell types closely intermingled: the platelets were associated already with each other, as well as with PMN. Platelets and PMN appeared in an advanced stage of interaction with a very close contact between membrane of both cell types (Fig 1A) . Figure 1B shows aggregates from a platelet sample stimulated by PMNderived supernatants. Many of the platelets had lost their granules and were in an advanced stage of shape change, secretion, and aggregation.
Cathepsin G measured in PMN suspensions activated by 1 pmol/L fh4LP for 1 minute averaged 0.18 pmol/L (ranges 0.15 to 0.22; n = 5). Cathepsin G enzymatic activity recovered in mixed cell suspensions preincubated with or without stirring was 54.4% ? 6.2% and 48.0% * 1.2% of the activity measured in PMN stimulated alone, respectively. Because azurophilic granule release, measured as p-glucuronidase, was in contrast not affected by the presence of platelets, the Measurement of cathepsin G enrymatic activity.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From supernatants was heat labile (5 minutes at 9OOC) and suppressed by preincubation with an antibody against cathepsin G, while it was unaffected by an anti-elastase monoclonal antibody (Fig 2) . Purified cathepsin G from human PMN (0.2 pmol/L) induced platelet activation at a similar extent as PMN supernatants. This activity, too, was completely prevented by the anti-cathepsin G antibody (Fig 
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Soybean Trypsin inhibitor (pLg/ml) For personal use only. on October 24, 2017. by guest www.bloodjournal.org From Purified cathepsin G added to mixed cell suspension induced platelet activation to a similar extent as that observed in fMLP-activated PMN.
Effects of antiproteinases. al-antitrypsin preincubated with platelet-PMN suspensions completely prevented the effect of exogenous cathepsin G but did not influence platelet activation induced by fMLP-stimulated PMN (Fig  3) . Figure 4 shows the effect of al-antitrypsin (from human plasma) on platelet activation induced by fMLP-stimulated PMN or by PMN-derived supernatants. The effect of PMN-derived supernatants was completely abolished by this antiproteinase (ICso: 130, 140, and 160 pg/mL for aggregation, Ca2+ increase, and TxB, production, respectively). In contrast, platelet activation in mixed cell suspensions challenged with fMLP appeared only partially affected.
Soybean trypsin inhibitor from soybean completely prevented platelet activation induced by PMN-derived supernatants. This effect was dose-dependent on the three parameters studied (IC5,,: 1.3, 1.0, and 2.0 pg/mL for aggregation, Ca2+ increase, and TxB, production, respectively). In contrast, platelet activation induced by PMN in mixed cellular suspensions was partially affected by soybean trypsin inhibitor only at concentrations of at least 10 to 20 times higher than that required to completely prevent supernatant activity (Fig 4) . Eglin C, a low molecular weight inhibitor of cathepsin G and elastase? completely blocked platelet stimulating material present in PMN supernatants (ICso: 6.5, 6.5, and 8 pg/mL for aggregation, Caz+ increase, and TxB, production, respectively), but only partially inhibited platelet activation in mixed cellular suspensions (Fig 4) .
Because hydrogen peroxide" and superoxide anion" have been shown to stimulate platelet function, the hypothesis that in mixed cellular suspensions short-lived radicals could play a role (either inducing per se platelet activation or potentiating the effect of released serine protease) was also tested. The effect of superoxide dismutase and catalase at concentrations that abolished cytochrome C reduction (both 50 pg/mL) was evaluated in mixed cellular suspensions activated by 1 pmol/L fMLP, in the presence or in the absence of soybean trypsin inhibitor (100 pg/mL). In these experiments oxygen radicals scavengers neither affected per se platelet activation nor significantly modified the activity of soybean trypsin inhibitor (Fig 5) .
Electron microscopic examination of stirred or unstirred platelet-PMN samples. Electron microscopic examination of stirred PMN-platelet suspensions preincubated for 2 minutes at 37°C before stimulation showed a close PMNplatelet contact with the formation of small clumps in which platelets appeared to contact to PMN membranes without any morphologic or biochemical event suggesting platelet activation. Figure 6A demonstrates several platelets having a discoid configuration in close proximity to neutrophils. In contrast, cells from an unstirred sample appeared dispersed and no platelet-PMN interaction was observed (Fig 6B) .
Effect of platelet-PMNprestining on efficacy of antiproteinases. To verify if PMN-platelet contact possibly occurring during preincubation with stirring may protect released cathepsin G from antiproteinases, the efficacy of these inhibitors on platelet activation induced by PMN was tested in mixed cell suspensions preincubated without stirring. Under these conditions subsequent aggregation and platelet cytoplasmic Ca2+ increase in control samples were not modified, but soybean trypsin inhibitor completely blocked platelet activation induced by PMN (Fig 7) . On the other hand al-antitrypsin at a concentration (200 pg/mL) that did not significantly affect aggregation or platelet cytoplasmic Caz+ increase under stirring conditions (15.5% & 7.6% and 16.6% & 2.5% inhibition), induced 50.3% & 7.6% and 62.2% 2 7.7% inhibition (means 2 SEM; n = 4) of aggregation and platelet cytoplasmic Ca2+ increase when cells were preincubated without stirring. Figure 8 shows the morphology of the PMN-platelet suspension preincubated without stirring for 2 minutes at 37°C with soybean trypsin inhibitor (100 p,g/mL) before stimulation with 1 pmol/L of For personal use only. on October 24, 2017. by guest www.bloodjournal.org From fMLP. In accordance with the biochemical findings, platelets preserved their discoid shape and did not appear to have been significantly activated even when they were in close association with PMN. PMN adhered to each other, while platelets appeared to resist the stimulation. In corresponding samples preincubated and stirred with the same concentration of soybean trypsin inhibitor, platelet and PMN were aggregated and both cells showed marked changes associated with activation, similar to the activated control sample (see Fig 1) .
DISCUSSION
In this study the prominent role of cathepsin G released by fMLP-stimulated PMN as a platelet activator was confirmed, as shown by the inhibitoq efficacy of specific antibodies. Previous reports had demonstrated that cathepsin G and elastase, two serine proteases, released by activated PMN stimulate platelet f~nction.'~.'~.'~ In particular, cathepsin G was able to induce platelet aggregation, cytoplasmic calcium increase, and serotonin release, acting as a strong platelet agonist. Its activity was independent of amplification mechanisms such as ADP release or TxA, production." Recently, Selak and Smith have identified a specific receptor for cathepsin G on the platelet surface, suggesting a role for this serine protease in platelet function." 
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Our results suggest that cathepsin G released in PMNplatelet suspensions is protected from different inhibitors. In fact, while antiproteinases such as al-antitrypsin, soybean trypsin inhibitor, and eglin C all prevented platelet activation induced by purified cathepsin G or by PMN supernatants separated from the cells, they were much less effective when platelets were activated by stimulated PMN in mixed cell suspensions.
A similar phenomenon related to the action of elastase released by activated PMN has been r e p~r t e d . "~'~,~~
The presence of PMN and platelets may protect released cathepsin G from various inhibitors, by at least two mechanisms: (1) inactivation of antiproteinases through oxidation mediated by free radicals released by PMN during respiratory burst activityY5 and (2) close contact between PMN and platelets that physically impede the antiproteinases to reach cathepsin G secreted in a protected microenvironment.
19.'0
The results obtained with soybean trypsin inhibitor, which is resistant to oxidation, indicate that short-lived oxygen radicals released by PMN in our system do not play an essential role in the described protection phenomenon. Weitz et all9 also found that oxidative inactivation of plasma proteinase inhibitors does not explain the failure of soybean trypsin inhibitor to prevent elastase-mediated fibrinogenolysis.
In addition, platelet-activating activity of oxygen radicals" does not seem to play a role in mixed cell suspensions, because superoxide dismutase (SOD) and catalase did not affect per se PMN-induced platelet activation nor potentiated the inhibitory effect of soybean trypsin inhibitor.
The second mechanism seems more likely, because a close contact between PMN and platelets occurs when cells were incubated under stirring conditions before addition of the stimulus, as shown by electron microscopy. Moreover, the protective effect was no more evident when the samples were not stirred during preincubation as a means to minimize cell-cell contact. Results from these experiments also showed that preincubation without stirring did not reduce the subsequent aggregation and platelet cytoplasmic Ca" increase that occurred when control samples were stirred upon addition of fMLP. In mixed cell suspensions preincubated with soybean trypsin inhibitor without stirring, platelet activation induced by PMN was totally suppressed. The same concentration of the inhibitor was only partially effective in prestirred samples (Fig 7) .
In parallel with biochemical parameters, electron microscopy of previously unstirred samples showed that platelets were not activated and had retained their discoid configuration. They were physically close to PMN, but the degree of interaction was very limited. Even so, PMN adhered each other, while platelets appeared to resist the stimulation. PMN and platelets looked simply mixed together with little cell-cell interaction going on. On the other hand, when samples containing soybean trypsin inhibitor were stirred before stimulation, PMN and platelets appeared to be aggregated, both cells demonstrating marked changes associated with activation.
These data are in agreement with the hypothesis that the close PMN-platelet contact occurring during preincubation of stirred samples before addition of the stimulus would create a microenvironment in which released cathepsin G accumulates at relatively high concentrations and is protected from inhibitors. This view is reinforced by the observation that the addition of purified cathepsin G to prestirred mixed cell suspensions induced full platelet activation, which was effectively prevented by antiproteinase inhibitors. In this case it is reasonable to suggest that exogenous cathepsin G was homogeneously distributed throughout the sample and was therefore rapidly inactivated by antiproteinases.
The mechanism(s) of platelet-PMN interaction in our system remain(s) to be elucidated. Mechanical stirring of the sample may induce some platelet stimulation leading to the adhesion of these cells to PMN, as shown for thrombinactivated platelet^.^^.^' Whatever the molecular mechanism of platelet-PMN interaction in our system, the protective phenomenon described for the first time in this paper suggests an interesting functional role for PMN-platelet adhesion.
